Business Context and Reporting Period
Company: Dyadic International, Inc. (DYAI)
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2026
Event: Entry into material definitive agreements for a registered direct offering of common stock and a concurrent private placement of warrants.
Key Financial Metrics and Transaction Details
This filing details a capital raise rather than reporting periodic operating results. Key transaction metrics include:
- Registered Offering: Sale of 3,625,000 shares of Common Stock at $0.795 per share.
- Concurrent Private Placement: Sale of warrants to purchase 3,625,000 shares of Common Stock at $0.005 per warrant.
- Warrant Exercise Price: $0.84 per share.
- Expected Gross Proceeds: Approximately $2.9 million (before offering expenses).
- Use of Proceeds: General corporate purposes, including R&D, sales and marketing, working capital, capital expenditures, and potential acquisitions.
Note: The filing does not provide current revenue, profit, cash flow, or debt figures as this is a transactional report, not a periodic financial statement.
Material Changes and Agreements
The Company entered into the following agreements on August 13, 2026:
- Purchase Agreements: Agreements with investors for the sale of shares and warrants.
- Registration Rights Agreement: The Company agreed to file a registration statement for the resale of warrant shares within 30 days of closing.
- Placement Agent Agreement: Entered into with Aegis Capital Corp.
Standstill Restrictions:
- The Company is restricted from issuing or selling additional equity or convertible securities for 90 days following the Release Date, with exceptions for acquisitions approved by disinterested directors.
- Directors, officers, employees, and shareholders holding 10% or more of outstanding stock are subject to a 90-day lock-up period prohibiting sales or hedging of the Company's securities.
Outlook, Risks, and Unusual Items
Closing Conditions: The closing of the offerings is expected on or about August 14, 2026, subject to customary closing conditions.
Risks: The transaction involves dilution to existing shareholders and the issuance of warrants with an exercise price ($0.84) higher than the current offering price ($0.795). The Company has agreed to indemnification obligations under the Purchase Agreements.
Unusual Items: None reported beyond the standard terms of the capital raise.
Investor Verification Checklist
- Verify the actual closing date and final gross proceeds once the transaction completes.
- Review the full text of the Common Stock Purchase Agreement and Warrant Securities Purchase Agreement (Exhibits 10.1 and 10.2) for specific covenants and redemption rights.
- Confirm the impact of the 90-day standstill restrictions on the Company's ability to raise additional capital or pursue M&A.
- Monitor the filing of the registration statement for the resale of warrant shares within the required 30-day window.